Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

GE Healthcare Limited
Sponsor

GE Healthcare Limited

United Kingdom Pollards Wood, Nightingales Lane, HP8 4SP, United Kingdom

About the sponsor

Research activity includes positron emission tomography and computed tomography applications in metastatic breast cancer, colorectal cancer, gastric cancer, ovarian cancer, pancreatic cancer, and head and neck squamous cell carcinoma. The portfolio also covers imaging of peritoneal carcinomatosis and other advanced solid tumours.

  • FES PET/CT
  • HER2 imaging
  • 68Ga PET/CT
  • Peritoneal carcinomatosis detection

Clinical interest extends to imaging biomarkers that support treatment selection and disease characterisation in advanced cancer.

About Specializations

GE Healthcare Limited runs clinical trials in conditions such as Gastric cancer, Colorectal cancer, Pancreatic carcinoma, Hepatic lesion, among others.

Recruiting now

Ongoing trials

Clinical trials run by this sponsor – those enrolling participants first.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

4 clinical trials

Gastric cancer+2

Recruiting

A study to evaluate the use of FAPI-46 (68Ga) imaging to detect peritoneal cancer spread in patients with colorectal, gastric, ovarian, or pancreatic cancer

InvestigationalNo placebo
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years · 65+ years
  • Substances:(S)-2,2',2''-(10-(2-(4-(3-((4-(2-(2-Cyano-4,4-Difluoropyrrolidin-1-Yl)-2-Oxoethylcarbamoyl)-Quinolin-6-Yl)(Methyl)Amino)-Propyl)Piperazin-1-Yl)-2-Oxoethyl)-68Ga-[1,4,7,10]-Tetraazacyclododecane-1,4,7-Triyl)Triacetate
  • Sponsor:GE Healthcare Limited

Hepatic lesion

Not yet recruiting

Safety and Effectiveness of Intravenous Sonazoid for Contrast-Enhanced Liver Ultrasound in Children with Focal Liver Lesions

Registered drugNo placebo
Countries:GermanyGermany
  • Participants:0–17 years
  • Substances:Perflubutane
  • Sponsor:GE Healthcare Limited

Scan myocardial perfusion+1

Not recruiting

Study on the Safety and Effects of Regadenoson and Gadobutrol in Heart Imaging for Children with Cardiovascular Conditions

Registered drugNo placebo
Countries:FranceFrance
  • Participants:0–17 years
  • Substances:Gadobutrol
  • Sponsor:GE Healthcare Limited

Breast cancer+5

Not recruiting

Study on the Impact of Fluoroestradiol F-18 PET on Treatment for Patients with ER+ HER2- Metastatic Breast Cancer After First-Line Hormone Therapy Relapse

Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Fluoroestradiol F-18
  • Sponsor:GE Healthcare Limited

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Join now →
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.